Related Experiment Video
Updated: Aug 25, 2026

Real-Time Polymerase Chain Reaction-Based Detection and Quantification of Hepatitis B Virus DNA
Published on: December 15, 2023
Molecular epidemiology of hepatitis B and C virus infections in Asia
1Department of Pathology, National Institute of Infectious Diseases, Tokyo, Japan.
Insights
Molecular epidemiology of hepatitis B virus (HBV) and hepatitis C virus (HCV) in Asia reveals genotype-specific disease severity and treatment responses. Understanding these viral factors is crucial for managing liver diseases and hepatocellular carcinoma in endemic regions.
Area of Science:
- Hepatology
- Virology
- Molecular Epidemiology
Background:
- Hepatitis B virus (HBV) and hepatitis C virus (HCV) are major causes of blood-borne infectious diseases globally.
- These viruses are particularly prevalent in Asia, leading to acute and chronic liver diseases, including liver cancer.
- Genotypic variations in HBV and HCV influence disease progression and treatment outcomes.
Purpose of the Study:
- To review the molecular epidemiology of HBV and HCV, focusing on Asia.
- To examine the relationship between viral genotypes, pathogenicity, and therapeutic sensitivity.
- To highlight the significance of HBV/HCV genotypes in liver disease and hepatocellular carcinoma.
Main Methods:
- Literature review of molecular-based epidemiology studies.
- Analysis of HBV and HCV genotype distributions and their geographic relevance.
- Examination of HBV mutants and HCV genotypes in relation to disease severity and treatment.
Main Results:
- HBV genotypes B and C are prevalent in Asia, with genotype C associated with more severe liver disease.
- Specific HBV mutants (pre-S, basal core promoter, YMDD, vaccine escape) are common in Asia and linked to disease severity and therapy response.
- HCV genotype 1 shows reduced sensitivity to interferon therapy and may cause more severe disease.
Conclusions:
- HBV and HCV genotypes play a significant role in the pathogenicity of chronic liver diseases and hepatocellular carcinoma.
- Understanding genotype-specific characteristics is vital for effective therapeutic strategies in endemic regions like Asia.
- Further research is needed to elucidate the complex interplay between HBV/HCV genotypes, disease progression, and treatment efficacy.
Abstract:
The present paper provides a review of the current literature regarding the molecular-based epidemiology of hepatitis B virus (HBV) and hepatitis C virus (HCV), which are very important viruses underlying the etiology of blood-borne infectious diseases worldwide. Particularly, both HBV and HCV are widespread on the Asian continent and are associated with acute and chronic liver diseases, including hepatocellular carcinoma. HBV has been classified into genotypes A through G and shown to have a distinct geographic distribution. In Asia, genotypes B and C of HBV prevail, and genotype C has been shown to cause more serious liver disease than genotype B. High prevalence of HBV mutants with various forms, such as the pre-S mutant, basal core promoter mutant, YMDD motif mutant and vaccine escape mutant, were seen in Asia and these were found to be related to the severity of liver disease and sensitivity to therapy. HCV has also been classified into multiple genotypes and associated with geographic distribution. HCV genotype 1 is less sensitive to interferon therapy and may be associated with the presence of more serious liver disease than the other genotypes. Data on the relation among the HBV/HCV genotypes, their pathogenicity in chronic liver diseases including hepatocellular carcinoma and their effect on therapy are awaited with great interest, especially in Asia, which is an endemic region of blood-borne hepatitis viruses.
Related Concept Videos
Hepatitis
Viral Hepatitis I: Introduction
Viral Mutations
Human Virome
Viruses with RNA Genomes
Yellow Fever

